Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor

Annals of Internal Medicine

Volumn 132, Issue 11, 2000, Pages 880-884

  Baumgartner, Iris ^a,c   Rauh, Guenter ^a,b   Pieczek, Ann ^a,b   Wuensch, Debra ^a,b   Magner, Meredith ^a,b   Kearney, Marianne ^a,b   Schainfeld, Robert ^a,b   Isner, Jeffrey M ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIURETIC AGENT; PLASMID DNA; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CLINICAL TRIAL; DIURETIC THERAPY; GENE TRANSFER; HOSPITALIZATION; HUMAN; INTERMITTENT CLAUDICATION; LEG EDEMA; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; OUTPATIENT; PAIN; PRIORITY JOURNAL; RECURRENT DISEASE; REST;

EID: 0034612203     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-132-11-200006060-00005     Document Type: Article

References (19)

1. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 1983;219:983-5.
2. Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol. 1999;237:97-132.
3. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989; 246:1306-9.
4. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 1989;246:1309-12.
5. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93:662-70.
6. Takeshita S, Tsurumi Y, Couffinahi T, Asahara T, Bauters C, Symes JF, et al. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest. 1996;75:487-501.
7. Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, et al. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation. 1996;94:3281-90.
8. 165 in patient with ischaemic limb. Lancet. 1996;348:370-4.
9. 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 1998;97:1114-23.
10. Isner JM, Baumgartner I, Rauh G, Schainfeld R, Blair R, Manor O, et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results. J Vasc Surg. 1998;28:964-73.
11. Isner JM. Arterial gene transfer for naked DNA for therapeutic angiogenesis: early clinical results. Advanced Drug Delivery. 1998;30:185-97.
12. Vale PR, Wuensch DI, Rauh GF, Rosenfield K, Schainfeld RM, Isner JM. Arterial gene therapy for inhibiting restenosis in patients with claudication undergoing superficial femoral artery ongioplasty [Abstract]. Circulation. 1998;98:1-66.
13. Isner JM, Walsh K, Symes J, Pieczek A, Takeshita S, Lowry J, et al. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum Gene Ther. 1996;7:959-88.
14. Isner JM, Walsh K, Rosenfield K, Schainfeld R, Asahara T, Hogan K, et al. Arterial gene therapy for restenosis. Hum Gene Ther. 1996;7:989-1011.
15. van der Zee R, Murohara T, Luo Z, Zollmann F, Passeri J, Lekutat C, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation. 1997;95:1030-7.
16. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, et al. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg. 1995;21:314-24.
17. Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, et al. Hypoxia-induced paracrine regulation of VEGF receptor expression. J Clin Invest. 1996;97:469-76.
18. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J Cell Sci. 1995;108:2369-79.
19. Murohara T, Horowitz J, Silver M, Tsurumi Y, Chen D, Sullivan A, et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation. 1998;97: 99-107.